PT-141 2mg/mL (5mL)

PT-141 (Bremelanotide) 2 mg/mL – 5 mL Vial is a synthetic peptide that acts as a melanocortin receptor agonist, primarily targeting MC3 and MC4 receptors in the central nervous system. It is used to modulate sexual arousal and desire in both men and women, working through neural pathways rather than vascular mechanisms like PDE5 inhibitors. The 5 mL vial at 2 mg/mL contains a total of 10 mg of PT-141, typically supplied as a sterile solution for reconstitution or subcutaneous administration in research or controlled clinical settings. PT-141 has been studied for hypoactive sexual desire disorder (HSDD) and shows rapid onset of action, with effects generally mediated via melanocortin receptor stimulation in the hypothalamus. Clinical studies demonstrate PT-141’s efficacy in improving sexual desire and arousal: https://pubmed.ncbi.nlm.nih.gov/20124485/ Mechanism of action via central melanocortin receptors: https://pubmed.ncbi.nlm.nih.gov/19467237/